Press Releases
-
Feb 24, 2021ENGLEWOOD, CO / ACCESSWIRE / February 24, 2021 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company focused on commercializing novel products that address significant patient needs, today announced that Josh Disbrow, Chairman and Chief Executive Officer will present at three upcoming investor conferences in March:...Feb 11, 2021Announced definitive merger agreement with Neos Therapeutics, creating a combined $100 million revenue specialty pharmaceutical company...Feb 10, 2021- Record date for each Special Meeting of Stockholders is February 5, 2021 -...Feb 4, 2021Live Conference Call and Webcast at 4:30 PM ET...